Reaction
Abdominal Compartment Syndrome reporting signals
As of the last recalculation, Abdominal Compartment Syndrome appears in 615 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 81.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 24 | 81.8 | 82.0 |
| Basiliximab | 15 | 44.2 | 44.3 |
| Piperacillin And Tazobactam | 12 | 32.4 | 32.4 |
| Norepinephrine | 10 | 32.2 | 32.2 |
| Amphotericin B | 11 | 30.2 | 30.3 |
| Mercaptopurine | 15 | 30.0 | 30.0 |
| Midazolam | 21 | 29.2 | 29.2 |
| Gentamicin | 11 | 29.0 | 29.0 |
| Midazolam Hydrochloride | 22 | 28.6 | 28.7 |
| Piperacillin Sodium And Tazobactam Sodium | 16 | 28.3 | 28.3 |
| Meropenem | 25 | 27.4 | 27.5 |
| Ganciclovir | 8 | 26.8 | 26.8 |
| Cefepime | 11 | 26.4 | 26.4 |
| Norepinephrine Bitartrate | 11 | 26.3 | 26.3 |
| Gentamicin Sulfate | 12 | 26.2 | 26.2 |
| Propofol | 27 | 26.1 | 26.1 |
| Ganciclovir Sodium | 8 | 25.9 | 25.9 |
| Piperacillin Sodium,Tazobactam Sodium | 19 | 25.0 | 25.0 |
| Melphalan | 16 | 24.4 | 24.4 |
| Melphalan Hydrochloride | 17 | 23.6 | 23.6 |
| Cefepime Hydrochloride | 11 | 23.5 | 23.5 |
| Heparin Sodium | 9 | 22.5 | 22.5 |
| Rocuronium Bromide | 7 | 20.3 | 20.3 |
| Tobramycin Solution | 7 | 19.9 | 19.9 |
| Tobramycin Sulfate | 7 | 19.3 | 19.4 |
| Etoposide | 39 | 19.1 | 19.1 |
| Vincristine Sulfate | 15 | 17.7 | 17.7 |
| Pegaspargase | 6 | 16.7 | 16.7 |
| Clobazam | 11 | 15.5 | 15.5 |
| Cetuximab | 14 | 15.5 | 15.5 |
| Lacosamide | 16 | 14.9 | 14.9 |
| Cisplatin | 31 | 14.1 | 14.1 |
| Sevoflurane | 3 | 12.3 | 12.3 |
| Clozapine | 41 | 11.8 | 11.8 |